Publications by authors named "Nadiyah Alshehri"
Article Synopsis
- - The study investigated how COVID-19 affected influenza prevalence in Saudi Arabia, comparing data from before (2017-2019) and during the pandemic (2020-2021) to assess the impact of intervention measures.
- - A total of 5,238 influenza cases were identified, revealing a significant decline during the pandemic years, with cases dropping from around 2% yearly pre-COVID-19 to 0.63% and 1.27% in 2020 and 2021, respectively.
- - The findings indicated that older individuals were more likely to be infected with influenza during the pandemic years, suggesting a shift in the demographic profile of patients compared to pre-pandemic times.
Background: Despite insufficient evidence, vitamin D has been used as adjunctive therapy in critically ill patients with COVID-19. This study evaluates the effectiveness and safety of vitamin D as an adjunctive therapy in critically ill COVID-19 patients.
Methods: A multicenter retrospective cohort study that included all adult COVID-19 patients admitted to the intensive care units (ICUs) between March 2020 and July 2021.
Background: Vancomycin is a commonly used antibiotic in critically ill patients for various indications. Critical illness imposes pharmacokinetic-pharmacodynamics challenges, which makes optimizing vancomycin in this population cumbersome. Data are scarce on the clinical impact of time to therapeutic trough levels of vancomycin in critically ill patients.
View Article and Find Full Text PDFBackground: Vancomycin is one of the most common therapeutic agents for treating gram-positive infections, particularly in critically ill patients. The aim of this study was to identify factors associated with initial therapeutic vancomycin trough levels and mortality in a tertiary-care intensive care unit (ICU).
Methods: This retrospective study evaluated 301 adult ICU patients admitted to King Abdulaziz Medical City in Riyadh between October 1, 2017 and December 31, 2018 with confirmed gram-positive infections and received intravenous vancomycin.